Sulzer drops plan to buy back share in medical arm
This article was originally published in Clinica
Executive Summary
Swiss industrial group Sulzer has been forced to abandon attempts to buy back from public ownership the 26% share of its medical business Sulzer Medica, following strong opposition from shareholders and analyst criticism. The company has conceded that a full flotation of the medical division is possible.